Search results
Sanofi (SNY) Relies on Dupixent and Vaccines to Drive Growth
Zacks via Yahoo Finance· 2 years agoDupixent has become the key top-line driver for Sanofi (SNY). Sanofi possesses a leading vaccine...
Sanofi's Biggest Drug Shined. But The Rest Of Its Business Didn't.
Investor's Business Daily· 3 months agoSanofi stock undercut its 50-day line Thursday despite Dupixent outperformance as its earnings...
Sanofi forecasts moderate profit growth on Dupixent demand
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi forecast moderate earnings growth that undershot expectations, saying demand for...
Sanofi's (SNY) Dupixent & Vaccines Make the Stock Attractive
Zacks via Yahoo Finance· 1 year agoOne can invest in Sanofi (SNY) due to the strong performance of Dupixent, above-market sales growth...
Sanofi (SNY) Q3 Earnings Beat, Dupixent, Flu Jabs Push Sales
Zacks via Yahoo Finance· 1 year agoSanofi (SNY) beats third-quarter estimates for earnings and sales. Dupixent and flu vaccines drive...
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
Motley Fool· 1 year agoLast month, Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) immunology mega-blockbuster, known...
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool· 1 year agoIn the middle of December, Sanofi's (NASDAQ: SNY) and Regeneron Pharmaceuticals' (NASDAQ: REGN)...
Sanofi (SNY) Q1 Earnings Beat, Sales Miss, Dupixent Strong
Zacks via Yahoo Finance· 12 months agoSanofi (SNY) beats first-quarter estimates for earnings but misses the same for sales. Higher sales...
Sanofi Sales, Profit Beat Expectations
The Wall Street Journal· 6 hours agoSanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength...
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – March 27, 2023 – Zacks.com announces the list of stocks featured...
